Golden Valley Memorial Healthcare in the News

Rated as One of the Top Hospitals in Missouri

Golden Valley Memorial Healthcare, a leading rural healthcare organization, has been rated among the top 10 hospitals in Missouri in a national hospital ranking index by the Lown Institute, a nonpartisan think tank based in Brookline, Mass.

The index, which was released in early July, assessed nearly 3,300 hospitals nationwide and rolls up scores from three categories, seven sub-components, and 42 detailed metrics to provide a unique and holistic ranking of hospital performance.

The hospitals on the Lown ranking received high value of care grades based on low use of unnecessary services. The quality of care metrics evaluated patient safety and health outcomes. Hospitals also earned marks in civic leadership by showing a commitment to diversity, inclusion, and community health.

These three pillars, along with data from the Internal Revenue Service, the Centers for Medicare and Medicaid, the Bureau of Labor Statistics, and the Securities and Exchange Commission, culminated in the ranking of hospitals. Overall, GVMH received an “A” for its ratings in these areas.

“We are extremely proud to have received an A ranking in the Lown Institute Hospitals Index and to be included as one of the top 10 hospitals in the entire state,” said Craig Thompson, CEO at GVMH. “Our communities rely on us in times of need and trust us with their lives, so it is important for us to deliver high-quality care. This index confirms the commitment and dedication of our staff.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”